14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $35.67 $41.84 Wednesday, 1st May 2024 CLDX stock ended at $39.35. This is 5.16% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 8.94% from a day low at $37.49 to a day high of $40.84.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
Nov 03, 2021 $46.26 $48.28 $45.59 $47.87 345 683
Nov 02, 2021 $44.76 $46.40 $43.45 $45.95 318 846
Nov 01, 2021 $41.71 $45.35 $41.18 $44.09 411 826
Oct 29, 2021 $44.72 $44.73 $42.41 $42.54 563 347
Oct 28, 2021 $44.60 $44.77 $43.69 $44.58 322 181
Oct 27, 2021 $46.03 $46.54 $44.42 $44.55 259 223
Oct 26, 2021 $47.35 $47.35 $45.56 $45.82 309 040
Oct 25, 2021 $47.77 $48.10 $46.16 $46.92 254 177
Oct 22, 2021 $46.31 $47.48 $45.16 $47.39 374 665
Oct 21, 2021 $46.62 $47.40 $46.13 $46.50 444 664
Oct 20, 2021 $45.06 $47.30 $45.06 $46.37 408 079
Oct 19, 2021 $45.32 $46.43 $45.29 $45.68 426 991
Oct 18, 2021 $45.80 $46.60 $44.73 $45.28 631 091
Oct 15, 2021 $47.78 $47.90 $46.05 $46.18 454 156
Oct 14, 2021 $47.68 $48.86 $45.76 $46.88 706 137
Oct 13, 2021 $51.16 $51.77 $47.71 $47.75 633 239
Oct 12, 2021 $52.87 $52.97 $50.83 $51.31 465 068
Oct 11, 2021 $53.55 $54.16 $52.03 $52.51 325 137
Oct 08, 2021 $55.26 $55.27 $53.91 $54.16 164 694
Oct 07, 2021 $53.38 $55.23 $52.56 $55.11 422 099
Oct 06, 2021 $55.33 $56.30 $52.91 $53.40 328 244
Oct 05, 2021 $56.50 $57.12 $55.27 $56.04 313 044
Oct 04, 2021 $55.64 $57.20 $55.44 $56.27 703 440
Oct 01, 2021 $55.00 $56.85 $53.60 $55.88 612 984
Sep 30, 2021 $51.96 $54.38 $51.96 $53.99 543 366
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT